Find participating medical centers and current study status in each of them

    Find participating medical centers

    A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)

    • Autoimmune Disorder
    • Rheumatoid Arthritis